Is This Anti-Aging Pill Legit?

Some have called it the most undervalued stock in the biotech space. Energy and Capital editor Jeff Siegel profiles a stock that has developed an anti-aging pill that could change humanity as we know it… Some have called it the most undervalued stock in the biotech space. Energy and Capital editor Jeff Siegel profiles a stock that has developed an anti-aging pill that could change humanity as we know it... [Wealth Daily logo] Is This Anti-Aging Pill Legit? [Jeff Siegel Photo] By [Jeff Siegel]( Written Jul 22, 2020 About 12 years ago, I decided to go vegan. Not for ethical or even health reasons –– I really just wanted to try it. I wanted to see what would happen... I wanted to experiment with new recipes within the confines of dietary restrictions. I wanted to see how it would affect my health, my mood, and my overall outlook on food... Truth is it wasn’t bad. "Small Pill Could Save Millions of Lives" — Kevin O’Leary [kevin oleary shark tank]( Chronic diseases like alcoholism, opioid addiction, diabetes, and depression can be a death sentence for millions of sufferers. Regular treatments work only 30% of the time and can take years. Now the FDA has given the go-ahead to a small pill that wipes out these diseases with just one or two doses. And elite research institutions, like Johns Hopkins, Stanford, and Harvard, have replicated and confirmed the results. "Mr. Wonderful," Kevin O’Leary, has already invested millions. [Details here...]( I actually enjoyed much of the food that I made, some of which I still make to this day. I’m a huge fan of Japanese winter stew, which is a hearty vegan meal that really hits the spot on a cold day. But I did end up eschewing the vegan diet for one that’s more of a healthy balance of meat, dairy, vegetables, fruit, and grains –– it just works for me. It gives me the nutrition I need to maintain my strict fitness regimen and sustain what I believe is optimal health. Of course, everyone’s body chemistry is different. For some, my diet, which is high in healthy fat and meat-based protein, may not work. For others, it may work great. A good friend of mine is actually a registered dietician, and she and I talk about this a lot. She tells me the biggest request she gets is for meal plans that will help her patients slow or reverse the aging process. Certainly, while there is no diet that can allow you to live forever, there are some things you can do to ensure that the food you’re eating doesn’t degrade your health, thereby speeding up the aging process. For her, clean eating is paramount: no processed foods, plenty of raw organic fruits and vegetables, healthy fats, meat-based protein (sourced from farms that employ regenerative farming practices), and no refined sugar. But even with a proper diet and exercise, she’ll still tell you that there is no diet in existence that can stop senescent cells from accumulating in your body. If you’re unfamiliar, senescent cells accumulate in your body as you age, and they secrete large quantities of harmful proteins that cause inflammation and tissue degradation. The result is aging and age-related diseases. Certainly, scientists have been studying this for decades, and there are plenty of registered dietitians, including my friend, who would love nothing more than to discover the perfect diet to counter the effects of cell senescence. But, the closest thing we have today to such a thing is a new class of anti-aging drugs known as senolytics. And there’s really only one company that’s made any real headway on this. Best Kept Secret of America’s Elite Exposed For decades, the country’s billionaires have been cashing in on a little-known income stream. Forbes calls it, "the biggest investment opportunity you’ve never heard of," and Business Insider describes it as, "one of the ‘very best’ income sources." But most Americans have no idea it even exists... until now. [Click here]( to learn how you can gain access to this income stream and start collecting $1,273, $3,127, or even $5,372 every single month. The “Fountain of Youth” Comes in a Pill Some have called it the most undervalued stock in the biotech space... Others have called it the most undervalued stock, period. After all, the company that’s developing these drugs is essentially creating a cure for aging by removing senescent cells –– something that’s never been done before in humans, but something that, if proven successful, could completely disrupt the health care industry forever. Imagine a health care industry that no longer had to treat age-related diseases because the cause of those diseases could effectively be removed. The value of such a drug would be superior to any drug available on the market today: opioids, allergy medications, even boner pills. We’re talking about a drug that could allow us all to live longer lives and without most diseases that come with aging. Of course, there’s no guarantee that the company developing these drugs will be successful. It could end up being a bust. But right now, this company is conducting clinical trials, and early results look promising. If this does end up hitting, this stock could easily double overnight. And while I’m not a huge gambler, I do understand the basic fundamentals of a risk-versus-reward scenario. And the reward for a company that could virtually end all age-related diseases? That’s just a no-brainer. I’ve personally been profiting from this company’s work in the field of senolytics, and I would encourage you to do the same. [Here’s a link to a report that explains how the drug works,]( and here’s a [link to a report]( I wrote that tells you more about the company, the drugs it's currently developing, and a list of some of the folks who have already invested in this company –– including Amazon CEO Jeff Bezos. Yeah, this is a no-brainer. [Click here to learn more.]( To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]@JeffSiegel on Twitter]( Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's [page](. Record-Breaking Gold Prices Are Coming It was just two months ago that I loaded up the kids and drove down to Florida. That was when most states were starting to slowly open after two months of stay-at-home orders. It was great! We went to a mostly secluded beach. What better way to social distance? Around two months later, states are starting to backpedal… closing beaches, putting more restrictions on restaurants, bars opening and now reclosing, etc.… The economic recovery is once again up in the air. And for the first time in almost a decade, gold is above $1,800/oz. That’s not all, dear reader. Experts from across the board are all saying the same thing — it's only a matter of time before gold prices reach higher than ever before. This surge in gold prices is mainly due to all the uncertainty in the market. But don’t go out right now and buy bullion. There’s a smarter way to play this and rake in quadruple-digit gains. In my newest report, I cover three gold stocks that I expect to skyrocket and could make you a millionaire. Naturally, loads of people are jumping at this opportunity, and I can’t give everyone a copy of this report. So time is of the essence. [Click here to check out each company.]( Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Apple Software Provider Readies Its IPO]( [Reverse Factoring: A Ticking Time Bomb in Corporate Books?]( [The Best Tech Stock Money Can Buy]( [Three 5G Stocks Under $10]( [Is Uber Afraid of a DoorDash IPO?]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2020, [Angel Publishing LLC](. All rights reserved. 3 E Read Street Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. ---------------------------------------------------------------